Celluris

Celluris is the first Latin America company developing personalized treatment for cancer patients through CAR-T immunotherapy. The therapy is based on the modification of the patient’s own cells that now can precisely recognize and kill tumoral cells.

Business Model: B2C for cancer patients

Product: In development

Stage: Validation

Want more information?

Site: www.cietec.org.br/project/celluris

Email: [email protected]

Go back